Arama Sonuçları - Bruno Vergès
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 52
- Sonraki Sayfaya Git
-
1
Lipid modification in type 2 diabetes: the role of LDL and HDL Yazar: Bruno Vergès
Baskı/Yayın Bilgisi 2009Revisão -
2
Pathophysiology of diabetic dyslipidaemia: where are we? Yazar: Bruno Vergès
Baskı/Yayın Bilgisi 2015Revisão -
3
Lipid disorders in type 1 diabetes Yazar: Bruno Vergès
Baskı/Yayın Bilgisi 2009Revisão -
4
Dyslipidemia in Type 1 Diabetes: A Masked Danger Yazar: Bruno Vergès
Baskı/Yayın Bilgisi 2020Revisão -
5
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms Yazar: Bruno Vergès
Baskı/Yayın Bilgisi 2020Revisão -
6
Intestinal lipid absorption and transport in type 2 diabetes Yazar: Bruno Vergès
Baskı/Yayın Bilgisi 2022Revisão -
7
ENDOCRINE SIDE EFFECTS OF ANTI-CANCER DRUGS: Effects of anti-cancer targeted therapies on lipid and glucose metabolism Yazar: Bruno Vergès, Thomas Walter, Bertrand Cariou
Baskı/Yayın Bilgisi 2013Revisão -
8
-
9
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity Yazar: Damien Denimal, Serge Monier, Benjamin Bouillet, Bruno Vergès, Laurence Duvillard
Baskı/Yayın Bilgisi 2023Revisão -
10
Concise review of lipidomics in nonalcoholic fatty liver disease Yazar: Sarah Béland-Bonenfant, Alexia Rouland, Jean‐Michel Petit, Bruno Vergès
Baskı/Yayın Bilgisi 2023Revisão -
11
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice Yazar: Tony Jourdan, Louiza Djaouti, Laurent Demizieux, Joseph Gresti, Bruno Vergès, Pascal Degrace
Baskı/Yayın Bilgisi 2010Artigo -
12
-
13
HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation Yazar: L. Perségol, Matthieu Foissac, Laurent Lagrost, Anne Athias, Philippe Gambert, Bruno Vergès, Laurence Duvillard
Baskı/Yayın Bilgisi 2007Artigo -
14
Adiponectin Is an Important Determinant of ApoA-I Catabolism Yazar: Bruno Vergès, Jean Michel Petit, Laurence Duvillard, Guillaume Dautin, E Florentin, F. Galland, Philippe Gambert
Baskı/Yayın Bilgisi 2006Artigo -
15
Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms Yazar: Bruno Vergès, Victor Aboyans, Denis Angoulvant, Pierre Boutouyrie, Bertrand Cariou, Fabien Hyafil, Kamel Mohammedi, Pierre Amarenco
Baskı/Yayın Bilgisi 2022Revisão -
16
Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts’ consensus statement Yazar: Sylvère Störmann, Sebastian M. Meyhöfer, Jan B. Groener, Johanna Faust, Katharina Schilbach, Jochen Seufert, Bruno Vergès
Baskı/Yayın Bilgisi 2024Artigo -
17
Glycated Albumin With Loss of Fatty Acid Binding Capacity Contributes to Enhanced Arachidonate Oxygenation and Platelet Hyperactivity: Relevance in Patients With Type 2 Diabetes Yazar: Denis Blache, Emmanuel Bourdon, Pauline Salloignon, Géraldine Lucchi, Patrick Ducoroy, Jean‐Michel Petit, Bruno Vergès, Laurent Lagrost
Baskı/Yayın Bilgisi 2014Artigo -
18
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study Yazar: Bruno Vergès, Françoise Boureille, Pierre Goudet, Arnaud Murat, Albert Beckers, Geneviève Sassolas, P Cougard, Béatrice Chambe, Corinne Montvernay, Alain Calender
Baskı/Yayın Bilgisi 2002Artigo -
19
Glycation of Apolipoprotein C1 Impairs Its CETP Inhibitory Property: Pathophysiological Relevance in Patients With Type 1 and Type 2 Diabetes Yazar: Benjamin Bouillet, Thomas Gautier, Denis Blache, Jean-Paul Paı̈s de Barros, Laurence Duvillard, Jean‐Michel Petit, Laurent Lagrost, Bruno Vergès
Baskı/Yayın Bilgisi 2014Artigo -
20
Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study Yazar: Jean‐Michel Petit, Jean–Pierre Cercueil, Romaric Loffroy, Damien Denimal, Benjamin Bouillet, C. Fourmont, Olivier Chevallier, Laurence Duvillard, Bruno Vergès
Baskı/Yayın Bilgisi 2016Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Cholesterol
Biology
Chemistry
Disease
Lipoprotein
Obesity
Insulin
Insulin resistance
Biochemistry
Gastroenterology
Lipid metabolism
Pathology
Apolipoprotein B
Fatty liver
Metabolic syndrome
Triglyceride
Very low-density lipoprotein
Body mass index
Environmental health
Steatosis
Type 1 diabetes
Adiponectin
Glycemic
Hormone
Liraglutide